# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Yi Chen maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and lowers the price target fro...
Lake Street analyst Ben Haynor maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and lowers the price target from $13 to $6.
Sensus Healthcare (NASDAQ:SRTS) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $...